Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

News Updates

More Articles Back to Article

New FDA-EMA Principles Redefine Expectations for AI in Drug Development

New FDA-EMA Principles Redefine Expectations for AI in Drug Development
Standard is evolving to become repeatable with oversight: consistent use in context, clear accountability with a human in the loop, and a record that holds up to scrutiny over time.

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.